Erik Helgstrand
Associate Director
Medical Science
Oxypharma
Sweden
Biography
R&D Consultant, Projipharma. Associate Professor with the Faculty of Pharmacy, BMC Uppsala. Earlier employments include: Research Director, Astra, Research Director, Pharmacia and Research Director with SBL Vaccine. Involvement with OxyPharma: Dr. Helgstrand was a project leader for the B-220 project in the mid 1990's. Today, he is involved in issues concerning toxicology studies and regulatory work.
Research Interest
His research interests lie in Healthcare and Medical Sciences. He is the Editor-in-Chief Member of many peer reviewed journals and his area of expertise credits him with many publications in national and international journals. He is committed to highest standards of excellence and it proves through his authorship of many books.
